We have successfully identified the presence of multiple tumorigenic fractions sporting the presence and absence of drug transporter proteins (SP1-SP2/MP1-MP2), which serve as ideal in vitro models to study tumor subtype transitions and plasticity. Here, SP2 is linked to neoplasm.